论文部分内容阅读
Background:Phosphodiesterase 4(PDE4)is a promising target for the treatment of Parkinson’s disease(PD).However,the underlying mechanism has not yet been well elucidated.Additionally,most of current PDE4 inhibitors produce severe nausea and vomiting respon